LabGenius
About Technology Applications Partnerships News Team Careers Contact
AboutTechnologyApplicationsPartnershipsNewsTeamCareersContact
LabGenius
Combining human and machine intelligence to accelerate the discovery of advanced medicines.
Catch the latest results from LabGenius' ML-driven T-cell engager optimisation capability in Labiotech.eu
In the MediaLabGeniusMay 16, 2023
Facebook0 Twitter Pinterest0 0 Likes
Previous

LabGenius' CEO & founder appeared live on Bloomberg News to talk about the drug discovery revolution that's taking place at the interface of biology and technology

In the MediaLabGeniusJune 8, 2023
Next

LabGenius Debuts T-cell Engager Optimisation Capability That Yields Molecules with >400-fold Tumour Killing Selectivity Versus Clinical Benchmark

Press ReleaseLabGeniusMay 15, 2023

Terms of Use | Privacy Notice

©LabGenius Limited 2024